A detailed history of China Universal Asset Management Co., Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,998 shares of JAZZ stock, worth $1.24 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
11,998
Previous 11,998 -0.0%
Holding current value
$1.24 Million
Previous $1.45 Million 0.07%
% of portfolio
0.19%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$115.19 - $132.77 $543,466 - $626,408
4,718 Added 64.81%
11,998 $1.45 Million
Q4 2023

May 21, 2024

SELL
$114.26 - $136.0 $539,078 - $641,648
-4,718 Reduced 39.32%
7,280 $895,000
Q4 2023

Jan 23, 2024

BUY
$114.26 - $136.0 $646,026 - $768,944
5,654 Added 347.72%
7,280 $895,000
Q3 2023

May 21, 2024

BUY
$122.0 - $145.31 $96,014 - $114,358
787 Added 93.8%
1,626 $210,000
Q3 2023

Oct 30, 2023

BUY
$122.0 - $145.31 $96,014 - $114,358
787 Added 93.8%
1,626 $210,000
Q2 2023

May 21, 2024

SELL
$122.5 - $147.16 $1,715 - $2,060
-14 Reduced 1.64%
839 $104,000
Q2 2023

Jul 27, 2023

SELL
$122.5 - $147.16 $1,715 - $2,060
-14 Reduced 1.64%
839 $104,000
Q1 2023

May 21, 2024

BUY
$133.98 - $160.47 $28,671 - $34,340
214 Added 33.49%
853 $124,000
Q1 2023

Apr 27, 2023

BUY
$133.98 - $160.47 $28,671 - $34,340
214 Added 33.49%
853 $125,000
Q4 2022

May 21, 2024

SELL
$129.72 - $159.85 $1.47 Million - $1.82 Million
-11,359 Reduced 94.67%
639 $101,000
Q4 2022

Jan 31, 2023

BUY
$129.72 - $159.85 $6,745 - $8,312
52 Added 8.86%
639 $102,000
Q3 2022

Oct 21, 2022

BUY
$126.59 - $161.18 $74,308 - $94,612
587 New
587 $78,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.49B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.